Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01272817 · ClinicalTrials.gov registry record · NA
Nonmyeloablative Allogeneic Transplant
A NA study, sponsored by Scripps Health.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT01272817 is a NA study that has completed, run by Scripps Health. The registered enrollment target is 36 participants.
The verdict
NCT01272817, a NA study, has completed, sponsored by Scripps Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
Allogeneic transplant from a matched sibling for the treatment of a variety of illnesses including bone marrow failure states, leukemias, myelodysplastic or myeloproliferative syndromes, lymphoma, or myeloma using a nonmyeloablative preparative regimen.
Interventions
- PROCEDURE Nonmyeloablative Allogeneic Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2001-10 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01272817
The ClinicalTrials.gov registry entry for NCT01272817 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Health, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nonmyeloablative Allogeneic Transplant is the first listed.
NCT01272817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01272817 about?
NCT01272817 is a clinical study titled "Nonmyeloablative Allogeneic Transplant". Allogeneic transplant from a matched sibling for the treatment of a variety of illnesses including bone marrow failure states, leukemias, myelodysplastic or myeloproliferative syndromes, lymphoma, or myeloma using a nonmyeloablative preparative regimen.
What is the current status of trial NCT01272817?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2001-10. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01272817?
The interventions under investigation include: Nonmyeloablative Allogeneic Transplant (PROCEDURE).
Who is sponsoring clinical trial NCT01272817?
This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.